Background: Many patients with obstructive lung disease (OLD) carry an inaccurate diagnostic label. Symptom-based questionnaires could identify persons likely to need spirometry. Objectives: We prospectively tested questions derived from a comprehensive literature review and an international Delphi panel to help identify chronic OLD (COPD) in persons with prior evidence of OLD. Methods: Subjects were recruited via random mailing to primary-care practices in Aberdeen, Scotland, and Denver, Colorado. Persons aged 40 and older reporting any prior diagnosis of OLD or any respiratory medications in the past year were enrolled. Participants answered 54 questions covering demographics and symptoms and underwent spirometry with reversibility testing. A study diagnosis of COPD was defined by fixed airway obstruction as measured by post-bronchodilator FEV1/FVC <0.70. We examined ability of individual questions in a multivariate framework to discriminate between persons with and without the study diagnosis of COPD. Results: 597 persons completed all investigations and proceeded to analysis. The list of 54 questions yielded 52 items for analyses, which was reduced to 19 items for entry into a multivariate regression model. Nine items had significant relationships with the study diagnosis of COPD, including increased age, pack-years, worsening cough, breathing-related disability or hospitalization, worsening dyspnea, phlegm quantity, cold going to the chest, and receipt of treatment for breathing. Individual items yielded odds ratios ranging from 0.33 to 20.7. This questionnaire demonstrated a sensitivity of 72.0 and a specificity of 82.7. Conclusions: A short, symptom-based questionnaire identifies persons more likely to have COPD among persons with prior evidence of OLD.

Keywords:
Asthma, Chronic obstructive pulmonary disease (COPD), Diagnosis, Primary care, Questionnaires, Spirometry, Validation studies
1.
McIvor A, Chapman KR: Diagnosis of chronic obstructive pulmonary disease and differentiation from asthma. Curr Opin Pulm Med 1996;2:148–154.
2.
van Schayck CP: Diagnosis of asthma and chronic obstructive pulmonary disease in general practice. Br J Gen Pract 1996;46:193–197.
3.
Bellia V, Battaglia S, Catalano F, Scichilone N, Incalzi RA, Imperiale C, Rengo F: Aging and disability affect misdiagnosis of COPD in elderly asthmatics: The SARA study. Chest 2003;123:1066–1072.
4.
van Weel C: Underdiagnosis of asthma and COPD: Is the general practitioner to blame? Monaldi Arch Chest Dis 2002;57:65–68.
5.
Korsten AMMH, van Schayck CP: New International Primary Care Airways Guidelines (IPAG). Rev Fr Allergol Immunol Clin 2003;43:246–248.
6.
den Otter JJ, van Dijk B, van Schayck CP, Molema J, van Weel C: How to avoid underdiagnosed asthma/chronic obstructive pulmonary disease? J Asthma 1998;35:381–387.
7.
Marklund B, Tunsater A, Bengtsson C: How often is the diagnosis bronchial asthma correct? Fam Pract 1999;16:112–116.
8.
Joyce DP, Chapman KR, Kesten S: Prior diagnosis and treatment of patients with normal results of methacholine challenge and unexplained respiratory symptoms. Chest 1996;109:697–701.
9.
Burney P: Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996;9:687–695.
10.
Jepson G, Butler T, Gregory D, Jones K: Prescribing patterns for asthma by general practitioners in six European countries. Respir Med 2000;94:578–583.
11.
Iqbal A, Schloss S, George D, Isonaka S: Worldwide guidelines for chronic obstructive pulmonary disease: A comparison of diagnosis and treatment recommendations. Respirology 2002;7:233–239.
12.
Global Initiative for Asthma: National Heart, Lung, and Blood Institute/World Health Organization Workshop Report: Global Strategy for Asthma Management and Prevention, updated April, 2002. Bethesda, National Institutes of Health, NIH Publication No. 02-3659. URL: www.ginasthma.com (accessed 13 Aug 2004).
13.
Ferguson GT, Enright PL, Buist AS, Higgins MW: Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest 2000;117:1146–1161.
14.
Anthonisen NR, Dik N, Manfreda J, Roos LL: Spirometry and obstructive lung disease in Manitoba. Can Respir J 2001;8:421–426.
15.
Tirimanna PR, van Schayck CP, den Otter JJ, van Weel C, van Herwaarden CL, van den Boom G, et al: Prevalence of asthma and COPD in general practice in 1992: Has it changed since 1977? Br J Gen Pract 1996;46:277–281.
16.
Beeh KM, Kornmann O, Beier J, Ksoll M, Buhl R: Clinical application of a simple questionnaire for the differentiation of asthma and chronic obstructive pulmonary disease. Respir Med 2004;98:591–597.
17.
Bennett J, Osman J, Blainey AD, Davies RJ: The assessment of a computer administered questionnaire in the differential diagnosis of asthma and chronic airflow limitation. Br J Dis Chest 1988;82:268–273.
18.
Price DB, Tinkelman DG, Halbert RJ, Nordyke RJ, Isonaka S, Nonikov D, et al: Symptom-based questionnaire for identifying chronic obstructive pulmonary disease in smokers. Respiration 2006 (in press).
19.
Chapman KR, Tashkin DP, Pye DJ: Gender bias in the diagnosis of COPD. Chest 2001;119:1691–1695.
20.
Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. National Institutes of Health, National Heart, Lung, and Blood Institute; April 2001 (updated 2003). URL: www.goldcopd.com (accessed 13 Aug 2004).
21.
Fagerstrom KO: Can reduced smoking be a way for smokers not interested in quitting to actually quit? Respiration 2005;72:216–220.
22.
National Institute for Clinical Excellence. Chronic obstructive pulmonary disease: national clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(suppl 1):i1–i232.
23.
Rudolf M: The reality of drug use in COPD: The European perspective. Chest 2000;117(2 suppl):29S–32S.
24.
Anis AH, Lynd LD, Wang XH, King G, Spinelli JJ, Fitzgerald M, et al: Double trouble: Impact of inappropriate use of asthma medication on the use of health care resources. CMAJ 2001;164:625–631.
25.
Peat JK, Toelle BG, Marks GB, Mellis CM: Continuing debate about measuring asthma in population studies. Thorax 2001;56:406–411.
26.
Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005–1012.
27.
van Schayck CP, Halbert RJ, Nordyke RJ, Isonaka S, Maroni J, Nonikov D: Comparison of existing symptom-based questionnaires for identifying COPD in the general practice setting. Respirology 2005;10:323–333.
28.
Chinn S, Jarvis D, Burney P: Relation of bronchial responsiveness to body mass index in the ECRHS. Thorax 2002;57:1028–1033.
29.
van Schayck CP, Loozen JM, Wagena E, Akkermans RP, Wesseling GJ: Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: Cross sectional case finding study. BMJ 2002;324:1370.
30.
Ferris BG: Recommended respiratory disease questionnaires for use with adults and children in epidemiological research: epidemiology standardization project. Am Rev Respir Dis 1978;118(6 pt 2):1–53.
31.
Minette A: Questionnaire on the European Community for Coal and Steel (ECSC) on respiratory symptoms: 1987 – updating of the 1962 and 1967 questionnaires for studying chronic bronchitis and emphysema. Eur Resp J 1989;2:165–177.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.